Results 271 to 280 of about 67,119 (304)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CD38 as an Immunomodulator in Cancer

Future Oncology, 2020
CD38 is a transmembrane glycoprotein that is widely expressed in a variety of human tissues and cells, especially those in the immune system. CD38 protein was previously considered as a cell activation marker, and today monoclonal antibodies targeting CD38 have witnessed great achievements in multiple myeloma and promoted researchers to conduct ...
Yanli, Li, Rui, Yang, Limo, Chen, Sufang, Wu   +3 more
openaire   +2 more sources

Kinetic competence of the cADP-ribose–CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling

Biochemical Journal, 2001
CD38/NAD+ glycohydrolase is a type II transmembrane glycoprotein widely used to study T- and B-cell activation and differentiation. CD38 is endowed with two different activities: it is a signal transduction molecule and an ectoenzyme that converts NAD+ into ADP-ribose (NAD+ glycohydrolase activity) and small proportions of cADP-ribose (cADPR; ADP ...
C, Cakir-Kiefer, H, Muller-Steffner, N, Oppenheimer, F, Schuber   +3 more
openaire   +2 more sources

Flavonoids as inhibitors of human CD38

Bioorganic & Medicinal Chemistry Letters, 2011
CD38 is a multifunctional enzyme which is ubiquitously distributed in mammalian tissues. It is involved in the conversion of NAD(P)(+) into cyclic ADP-ribose, NAADP(+) and ADP-ribose and the role of these metabolites in multiple Ca(2+) signaling pathways makes CD38 a novel potential pharmacological target.
Kellenberger, Esther, Kuhn, Isabelle, Schuber, Francis, Muller-Steffner, Hélène   +3 more
openaire   +3 more sources

Murine CD38: an immunoregulatory ectoenzyme

Immunology Today, 1995
CD38 is an ectoenzyme that utilizes NAD+ and is expressed by many cells of hematopoietic origin. Antibodies to CD38 potentiate many biological activities on lymphocytes, including induction of murine B-cell proliferation. In this article, Frances Lund and colleagues summarize information concerning the expression, enzymatic activity and signal ...
Frances Lund, Nanette Solvason, J.Christopher Grimaldi, R. Michael, E. Parkhouse, Maureen Howard   +5 more
openaire   +2 more sources

CD38-mediated ribosylation of proteins

The Journal of Immunology, 1995
Abstract The lymphocyte cell-surface Ag CD38 catabolizes NAD to adenosine 5' diphosphoribose (ADPR) and cyclic ADPR (cADPR). We show here that the soluble extracellular domain of CD38 (sCD38) mediates ADP ribosylation of several proteins. This was demonstrated by mass spectrometric analyses which revealed the addition of mass in units of
J C, Grimaldi, S, Balasubramanian, N H, Kabra, A, Shanafelt, J F, Bazan, G, Zurawski, M C, Howard   +6 more
openaire   +2 more sources

CD38: what is it there for?

Blood, 2003
CD38 is very much a molecule of the moment. Since it has been mentioned in well over 1000 articles in the past 5 years, we are entitled to ask, “What is it there for?” It is a type II transmembrane glycoprotein, the extracellular domain acting as an ectoenzyme, catalyzing the conversion ...
openaire   +1 more source

CD38 is a marker of human lacteals

Virchows Archiv, 2002
CD38 is a type II transmembrane glycoprotein involved in signaling and adhesion which is expressed mainly by immature hematopoietic cells and activated lymphoid cells. Central lymphatic channels of human small intestinal villi, the so-called lacteals, were coincidentally found to express CD38. Gastric and large intestinal mucosae, pancreas, liver, lung,
Inger Nina, Farstad, Fabio, Malavasi, Guttorm, Haraldsen, Henrik Sverre, Huitfeldt, Per, Brandtzaeg   +4 more
openaire   +2 more sources